Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds
Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers
Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds
GSK HPV Vaccine Offers Protection From 4 HPV Types
Aspirin Use Associated With Lower Cancer Indicence, Death
Early ADT Doesn’t Offer Survival Advantage—ASCO
Gleevec Decreases Recurrence Of Gastrointestinal Tumor
NCI-Approved Cancer Center, Cooperative Group Trials
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
